The BCL‐2 family protein inhibitor ABT‐737 as an...

  • Main
  • 2020 / 07
  • The BCL‐2 family protein inhibitor ABT‐737 as an...
Molecular Oncology 2020 / 07

The BCL‐2 family protein inhibitor ABT‐737 as an additional tool for the treatment of EBV‐associated post‐transplant lymphoproliferative disorders

Robert, Aude, Pujals, Anaïs, Favre, Loetitia, Debernardi, Justine, Wiels, Joëlle
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Journal:
Molecular Oncology
DOI:
10.1002/1878-0261.12759
Date:
July, 2020
File:
PDF, 20.25 MB
2020
Conversion to is in progress
Conversion to is failed